Jasper Therapeutics Statistics

Total Valuation

JSPR has a market cap or net worth of $64.60 million. The enterprise value is -$5.23 million.

Market Cap	64.60M
Enterprise Value	-5.23M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, before market open.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

JSPR has 15.02 million shares outstanding. The number of shares has increased by 39.72% in one year.

Current Share Class	15.02M
Shares Outstanding	15.02M
Shares Change (YoY)	+39.72%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	1.26%
Owned by Institutions (%)	72.93%
Float	9.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.05
P/TBV Ratio	1.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.03.

Current Ratio	4.98
Quick Ratio	4.70
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -101.73% and return on invested capital (ROIC) is -65.85%.

Return on Equity (ROE)	-101.73%
Return on Assets (ROA)	-54.52%
Return on Invested Capital (ROIC)	-65.85%
Return on Capital Employed (ROCE)	-117.90%
Revenue Per Employee	n/a
Profits Per Employee	-$1.11M
Employee Count	64
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.35% in the last 52 weeks. The beta is 2.24, so JSPR's price volatility has been higher than the market average.

Beta (5Y)	2.24
52-Week Price Change	-85.35%
50-Day Moving Average	5.65
200-Day Moving Average	16.40
Relative Strength Index (RSI)	28.26
Average Volume (20 Days)	243,831

Short Selling Information

The latest short interest is 1.67 million, so 11.10% of the outstanding shares have been sold short.

Short Interest	1.67M
Short Previous Month	2.08M
Short % of Shares Out	11.10%
Short % of Float	16.83%
Short Ratio (days to cover)	4.86

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-76.24M
Pretax Income	-63.93M
Net Income	-71.27M
EBITDA	-74.87M
EBIT	-76.24M
Earnings Per Share (EPS)	-$4.89

Full Income Statement

Balance Sheet

The company has $71.64 million in cash and $1.81 million in debt, giving a net cash position of $69.82 million or $4.65 per share.

Cash & Cash Equivalents	71.64M
Total Debt	1.81M
Net Cash	69.82M
Net Cash Per Share	$4.65
Equity (Book Value)	61.67M
Book Value Per Share	4.11
Working Capital	60.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$62.60 million and capital expenditures -$552,000, giving a free cash flow of -$63.15 million.

Operating Cash Flow	-62.60M
Capital Expenditures	-552,000
Free Cash Flow	-63.15M
FCF Per Share	-$4.20

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

JSPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.72%
Shareholder Yield	-39.72%
Earnings Yield	-110.33%
FCF Yield	-97.77%

Analyst Forecast

The average price target for JSPR is $62.50, which is 1,353.49% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$62.50
Price Target Difference	1,353.49%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	4.53%

Stock Forecasts

Stock Splits

The last stock split was on January 4, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jan 4, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1